Russell Investments Group Ltd. Has $457,000 Position in Teladoc Health, Inc. (NYSE:TDOC)

Russell Investments Group Ltd. trimmed its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 98.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,128 shares of the health services provider's stock after selling 1,815,354 shares during the quarter. Russell Investments Group Ltd.'s holdings in Teladoc Health were worth $457,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. International Assets Investment Management LLC raised its stake in Teladoc Health by 1,777.0% during the 4th quarter. International Assets Investment Management LLC now owns 112,038 shares of the health services provider's stock valued at $2,414,000 after purchasing an additional 106,069 shares during the last quarter. Lecap Asset Management Ltd. acquired a new position in Teladoc Health during the 4th quarter valued at $1,530,000. Sowell Financial Services LLC raised its stake in Teladoc Health by 40.8% during the 4th quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider's stock valued at $407,000 after purchasing an additional 5,475 shares during the last quarter. Deutsche Bank AG increased its holdings in Teladoc Health by 12.4% in the 3rd quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider's stock valued at $5,598,000 after buying an additional 33,287 shares during the period. Finally, Sherbrooke Park Advisers LLC bought a new stake in Teladoc Health in the 3rd quarter valued at $680,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

TDOC has been the topic of several analyst reports. SVB Leerink initiated coverage on shares of Teladoc Health in a report on Monday, February 26th. They issued a "market perform" rating and a $17.00 price target on the stock. Piper Sandler lowered their price target on shares of Teladoc Health from $30.00 to $25.00 and set an "overweight" rating on the stock in a report on Wednesday, February 21st. Citigroup lowered their price target on shares of Teladoc Health from $21.00 to $19.00 and set a "neutral" rating on the stock in a report on Wednesday, February 21st. Evercore ISI lowered their price target on shares of Teladoc Health from $15.00 to $14.00 and set an "in-line" rating on the stock in a report on Friday, April 26th. Finally, Royal Bank of Canada lowered their target price on shares of Teladoc Health from $25.00 to $18.00 and set an "outperform" rating on the stock in a report on Friday, April 26th. Thirteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and an average target price of $18.22.

Teladoc Health Price Performance

NYSE:TDOC traded up $0.09 during mid-day trading on Wednesday, reaching $11.92. 3,588,793 shares of the company were exchanged, compared to its average volume of 4,854,590. Teladoc Health, Inc. has a 12 month low of $11.67 and a 12 month high of $30.41. The company has a fifty day moving average of $13.73 and a 200 day moving average of $17.08. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. The stock has a market cap of $2.02 billion, a PE ratio of -8.45 and a beta of 0.97.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The company had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. During the same period in the prior year, the company earned ($0.37) EPS. The firm's revenue was up 2.7% compared to the same quarter last year. On average, research analysts anticipate that Teladoc Health, Inc. will post -1.04 EPS for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the company's stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the company's stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the sale, the insider now owns 86,070 shares in the company, valued at $1,092,228.30. The disclosure for this sale can be found here. In the last three months, insiders have sold 137,368 shares of company stock worth $1,968,587. Company insiders own 0.95% of the company's stock.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.